| abstract |
therapeutic or prophylactic agent for diabetes, obesity, dyslipidemia or metabolic syndrome, method for therapy or prophylaxis of diabetes, obesity, dyslipidemia or metabolic syndrome, and use of a benzylamine derivative a therapeutic or prophylactic agent for diabetes, obesity is disclosed. , dyslipidemia or metabolic syndrome, which may exhibit significant efficacy at a low dose and do not produce increased heart rate activity or qt interval prolongation activity that is an adverse side effect on the circulatory system. Specifically disclosed is a therapeutic or prophylactic agent for diabetes, obesity, dyslipidemia or metabolic syndrome comprising a benzylamine derivative represented by the formula or a pharmaceutically acceptable acid addition salt thereof. |